# Genetics of Response to Canagliflozin

> **NCT02891954** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 700 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Canagliflozin

## Key facts

- **NCT ID:** NCT02891954
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-09
- **Primary completion:** 2023-09-25
- **Final completion:** 2026-12-25
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02891954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02891954, "Genetics of Response to Canagliflozin". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT02891954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*